Skip to main content
Translate
Senior patient and doctor viewing tablet

Performance and Volume Data

Inova Heart and Vascular Institute
Translate

Select a Program or Service to View Performance and Volume Data

Acute Myocardial Infarction (AMI)

AMI 30-Day All-Cause Risk Adjusted  Readmissions (Medicare 65+)

ami readmissions chart

YTD 1/1/21 - 9/30/21


AMI Mortality Performance

ami mortality chart

YTD 1/1/21 – 9/30/21

Vizient Healthcare Database is one of the most comprehensive healthcare databases and is routinely utilized by the pharmaceutical and device industries, academia, healthcare insurers, and healthcare policymakers for clinical, financial and outcomes analyses. Expected readmissions and mortality performance are based on Vizient’s Standard Practice Risk Methodology.

NCDR seals


Patient Transfers

One Call 24/7  I  Adult: 703-776-5905  I  Pediatric: 877-900-9543 

Direct admission • Transfer • Specialized transport

Advanced Heart Failure

VAD and Heart Transplant Volumes

  2021
VAD Volume – Durable Devices 24
Heart Transplant Volumes 56
Heart - Lung Transplant Volume 1

gold seal The Joint Commission Gold Seal of Approval® for Ventricular Assist Device

 

Heart Transplant Survival

2022 Expected Observed Risk Ratio
Patient Survival (1 year) 91.65% 96.02% .63

SRTR January 2022 Report


Ventricular Assist Device (VAD) Post-Implant Survival

Years after device implant Intermacs IFH 
(VAFH-0151)
1 80.2% 80.4%
2 70.1% 72.9%
5 42.6% 50.9%

STS Intermacs 6/06 – 9/21

Mitch Psotka, MD, PhD

Mitch Psotka, MD, PhD


Heart Transplant and VAD Volumes chart

Urgent Access Heart Failure Clinics Offering Same-Day or Next-Day Appointments – Now at Three Inova Hospitals


Refer a Patient

703-776-6453 I heartfailure@inova.org
inova.org/ahf

Cardiac and Respiratory Failure

gold sealExtracorporeal Life Support Organization

Gold Level ELSO Award for Excellence in Life Support: The Cardiac, Critical Care and Lung Services teams at Inova Fairfax Medical Campus have been designated a Gold Level Center of Excellence. This award recognizes the highest level of performance, innovation, satisfaction and quality.

 

ECMO

  2017 2018 2019 2020 2021
Days of Support 740 848 1,047 1,485 1,727
Hours of Support 16,901 19,269 23,797 33,949 39,661
           
Pediatric ECMO Runs 12 8 20 18 16
Adult ECMO Runs 68 83 93 124 141
Total ECMO Runs 80 91 113 142 157

1/1/21 – 12/31/21


Impella® Volumes and Cardiogenic Shock Activations

  2018 2019 2020 2021
Impella Volume 110 100 90 72
Shock Team Activations 158 222 216 351

1/1/21 – 12/31/21


Cardiogenic Shock Patient Survival

1/1/21 – 12/31/21

cardiogenic shock patient survival chart

Cardiogenic Shock Program Continues to Achieve Outstanding Results


Patient Transfers

One Call 24/7 I Adult: 703-776-5905 I Pediatric: 877-900-9543

Direct Admission • Transfer • Specialized Transport

Cardiac Surgery

STS National Database Participant logo

red stars

Society of Thoracic Surgery
Highest rating for quality of:

  • Coronary Artery Bypass Surgery: 2016, 2017, 2018, 2019, 2020, 2021
  • Aortic Valve Replacement + Coronary Artery Bypass Grafting (CABG): 2017, 2018, 2019, 2020, 2021
  • Aortic Valve Replacement: 2021
  • Mitral Valve Repair or Replacement (MVRR) + CABG: 2017-2019

The Society of Thoracic Surgery (STS) is a national leader in health care transparency and accountability. The STS has developed a comprehensive rating system for the quality of cardiac surgery care among hospitals across the country based on overall performance, survival, complications and other measures. Approximately 12 – 15 percent of hospitals receive a “3-Star” rating, which denotes the highest category for quality. Further details can be found at publicreporting.sts.org.

Photo of two doctors

(L to R)
Eric Sarin, MD, Section Chief Adult Cardiac Surgery; Co-Director, Structural Heart Program; Co-Director, Cardiothoracic Surgery Research
Alan Speir, MD, Senior Associate Director, IHVI; Director, Cardiac Surgery


Mitral Valve Repair sealThe 2022 Mitral Valve Repair Reference Center Award recognizes the nation’s best hospitals and surgeons for mitral valve repair surgery based on objective performance measures.

Total Surgical Valve Volume – Isolated and Combined Procedures
YTD 1/1/21 – 9/30/21

Total Surgical Valve Volume – Isolated and Combined Procedures

Isolated CABG Mortality
YTD 1/1/21 – 9/30/21

Isolated CABG Mortality

Isolated CABG Intra-Op Blood Products Used
YTD 1/1/21 – 9/30/21

Isolated CABG Intra-Op Blood Products Used

Isolated CABG Post-Op Blood Products Used
YTD 1/1/21 – 9/30/21

Isolated CABG Post-Op Blood Products Used

CABG Combined Volume

CABG Combined Volume

*STS benchmark data for 2021 were not yet available at time of publication.


Refer a Patient

703-472-4600
inova.org/cvsurg

Congenital Heart Disease

Thanks to advances in pediatric cardiac care, there is a growing population of adults with congenital heart disease who previously might not have survived childhood.

Established in 1994 as a partnership between Inova Children’s Hospital and IHVI, Inova’s Adult Congenital Heart Disease (ACHD) Program was one of the first such programs in the country. Today, the ACHD program provides complete continuity of care for patients with a variety of congenital heart defects, including those complicated by heart rhythm problems, heart failure and pulmonary hypertension.

The ACHD program also partners with Inova Women’s Hospital to achieve the safest delivery possible for mothers with congenital heart defects and their babies.

The ACHD clinic is located in IHVI’s Advanced Disease Management Clinic, on Inova Fairfax Medical Campus. This provides patients seamless access to the collective expertise of Inova’s highly skilled pediatric and adult specialists in a single location, to improve outcomes and enhance quality of life.

Areas of specialization cover the full range of IHVI’s advanced cardiac therapies including:

  • Adult congenital cardiac catheterization
  • Adult congenital EP
  • Adult congenital surgery
  • Proactive evaluation of tetralogy patients
  • Maternal-fetal medicine

Neonatal Procedures

  2021
Complex Cardiac Repairs 18
PDA Ligations – Premature Infant 7
Total 25

YTD 01/01/2021 – 11/30/2021


Pediatric Congenital Heart Surgery and Procedures

  2021
Anomalous Coronary Surgery 1
ASD 4
ASO 2
AVC (Complete, Partial) 1
AVR/Supra-Sub AS 2
COA/Hypoarch 6
COA Nonpump 2
ECMO Cannulation 9
ECMO Procedures 21
Glenn/Fontan 8
MV Repair/Replacement 0
NORWOOD/STAT 5 0
PAPVR 0
PDA 7
PVR/Conduit/RVOT Procedure 4
Systematic Pulmonary Shunt 1
TAPVR 3
Thoracic Procedure 5
TOF 3
Tricuspid Valve 1
VSD 9
Other STAT Categories 9
Other Cardiac Nonpump 29
Total 130

YTD 01/01/2021 – 11/30/2021


Adult Congenital Heart Surgery

  2021
Anomalous Coronary Surgery 6
ASD 2
AVC (Partial, Transitional) 0
AVR/ASAA/Sub AS 1
MVR 1
PVR 7
PAPVR 2
VSD 0
Other 7
Total 26

YTD 01/01/2021 – 11/30/2021

Congenital Heart Disease Patient Gets Second Surgery and Second Chance


Refer a Patient

Adult Congenital Heart Program I 703-776-3599
Pediatric Congenital Heart Program I 703-776-4428
Fetal Congenital Heart Program I 703-776-6371
inova.org/chd

Electrophysiology

Adult and Pediatric Ablation Volumes
2021 Annualized YTD 1/1/21 – 9/30/21

ablation volumes

Adult and Pediatric Device Implant Volumes
2021 Annualized YTD 1/1/21 – 9/30/21

device implant volumes

IAC seal cardiac electrophysiology2021 Lead Extraction Procedures for cardiovascular implantable electronic devices (CIED): 55

2021 WATCHMAN™ Left Atrial Appendage Closure Implant Procedures: 111

Accredited for:

  • Testing and Ablation
  • Device Implantation
  • Chronic Lead Extraction

Atrial Fibrillation (AFib) Ablation Consultations and Procedures Now Available at Inova Loudoun Hospital

Inova's Innovative Multidisciplinary Approach to AFib Care


Refer a Patient

571-472-3270  I  arrhythmia@inova.org | inova.org/arrhythmia

Inova AFib Center

571-472-2342 I afib@inova.org I inova.org/afib

Inova Lung Services

"Our unique combination of expertise and experience constituted by highly talented individuals across multiple disciplines within our advanced lung disease team allows us to offer a breadth of subspecialized services for complex lung diseases that is difficult to match. Our approach is one of comprehensive, seamless, integrated and individualized care throughout the patient journey.” – Steven Nathan, MD, FCCP, Medical Director, Inova Advanced Lung Disease and Lung Transplant Program

Unique Patients Folllowed in 2021: 1,964

unique lung patients followed pie chart


1 of 20 centers in U.S. to hold all 5 designations

2021 Lung Transplant Volume:  28
2021 Heart – Lung Transplant Volume: 1


Lung Transplant Survival – Adult

  Observed US Average
Adult Patient Survival (1 year) 95.24% 88.76%

Scientific Registry of Transplant Recipients survival data as of release date 1/6/2022.

After a Lung Transplant, a Mother Gets a Second Chance

Inova's Multidisciplinary Approach to Treating Chronic Thomboembolic Pulmonary Hypertension (CTEPH)


Refer a Patient

703-776-7939  I  ltxreferrals@inova.org | inova.org/lung

To Discuss a CTEPH Case or Refer a Patient

703-776-6168 I phreferrals@inova.org I inova.org/ph

Interventional Cardiology

Cardiac Catheterization and Percutaneous Coronary Intervention (PCI) Volumes

YTD 1/1/21 – 9/30/21

Facility 2021
Inova Fairfax Medical Campus 4,028
Inova Alexandria Hospital 900
Inova Loudoun Hospital 753
Inova Heart and Vascular Institute Total 5,681
 
interventional cardiology data

Structural Heart Disease Program

Eric Sarin, MDOur highly experienced team is dedicated to improving survival and quality of life for people suffering from structural heart disease.

Using the combined expertise of cardiac surgeons, interventional cardiologists, radiologists specializing in cardiac imaging and nurse practitioners, we focus on providing a comprehensive assessment to identify the best course of treatment for patients with valvular heart disease or AFib patients undergoing a procedure for stroke risk reduction.

Pictured: Eric Sarin, MD, Co-Director, IHVI Structural Heart Program; Section Chief, Adult Cardiac Surgery; Co-Director, Cardiovascular Research

We utilize a minimally invasive approach whenever possible for the following procedures:

  • Transcatheter repair of intracardiac structures
  • Repair or replacement of mitral, aortic, pulmonic and tricuspid valves
  • Left atrial appendage closure (LAAC) for stroke risk reduction in patients with AFib

IHVI has a state-of-the-art hybrid operating room where cardiac surgeons, cardiologists and electrophysiologists operate together, resulting in fewer complications and shorter recovery periods for patients.

"When we talk about structural heart and valve disease, we’re referring to dysfunctions related to the valves or walls separating the chambers of the heart. Historically, these were managed with open heart surgery. With the explosion in technology over the last decade, we can now treat these patients just as effectively using a minimally invasive approach."

– Eric Sarin, MD

Clinical Trial: Repairing Tricuspid Valves Without Open Surgery

Clinical Trial: Inova Heart and Vascular Institute Explores Implant’s Potential to Replace Anticoagulants in AFib Stroke Prevention

TAVR 30-Day Mortality
YTD 1/1/21 – 9/30/21

TAVR 30-Day Mortality

Combined Aortic Valve Cases

Combined Aortic Valve Cases

TAVR Median Postprocedure Length of Stay
YTD 1/1/21 – 9/30/21

TAVR Median Postprocedure Length of Stay

MitraClip®and WATCHMAN Procedures
1/1/21 - 12/31/21

MitraClip®and WATCHMAN Procedures


Minimally Invasive PFO Closures in 2021: 104


Refer a Patient

703-776-3135  I  valve@inova.org
inova.org/structuralheart

Vascular Services

Vascular Procedure Volumes

  2021
Carotid Endarterectomy 229
Endovascular Abdominal Aortic Aneurysm (AAA) Repair * 62
Infrainguinal Bypass 120
Peripheral Vascular Interventions (PVI) ** 2,017

2021 rolling 4Q ending Q2 2021
2021 PVI annualized from YTD January – September data
*Performed by aortic team – vascular surgery and interventional radiology
**Volumes combined for vascular surgeons and interventional radiology

The Society for Vascular Surgery Vascular Quality Initiative (VQI®) is a collaboration intended to improve the quality, safety, effectiveness and cost of vascular healthcare. Data displayed here represent only procedures and surgeries performed at IHVI’s Inova Fairfax Medical Campus. The timeframe covers only Q1 and Q2 data for both Inova Fairfax Medical Campus and the benchmark data. Q3 and Q4 data were not yet available at time of publication.

Endovascular AAA Repair – Periprocedural Mortality

Inova All Other Regional Participants All Other National Participants
0% 1.10% 0.60%
 

Endovascular AAA Repair – Periprocedural Length of Stay

Inova All Other Regional Participants All Other National Participants
2.0 + 2.9; 1.0 2.4 + 3.5; 1.0 2.7 + 11.6; 1.0
 

Carotid Endarterectomy – Perioperative Mortality

Inova All Other Regional Participants All Other National Participants
0.0% 0.20% 0.60%
 

Carotid Endarterectomy – Perioperative Length of Stay

Inova All Other Regional Participants All Other National Participants
2.3 + 2.9; 1.0 2.6 + 4.1; 1.0 3.1 + 10.0; 1.0
 

Infrainguinal Bypass – Periprocedural Mortality

Inova All Other Regional Participants All Other National Participants
0.00% 1.20% 1.30%
 

Infrainguinal Bypass – Perioperative Length of Stay

Inova All Other Regional Participants All Other National Participants
5.6 + 4.7; 3.0 7.8 + 8.4; 5.0 9.7 + 63.7; 6.0
 

Value of the variables are displayed as mean + standard deviation; median.

Urgency of Endovascular AAA Repair

urgency of endovascular aaa repair

 

Intersocietal Accreditation Commission sealOutpatient Vascular Ultrasound Studies 14,944
January - December 2021

Multidisciplinary Approach to Treating Complex Wounds


Refer a Patient

571-472-4600 l vascular@inova.org | inovavascular.org

Inova Wound Healing Centers

703-664-8025 I inova.org/wound

Refer/Transfer

Refer a Patient – IHVI Cardiac Connect

Phone: 877-634-6682
Fax: 571-665-6882

Use this number for:

  • Cardiology consults
  • Diagnostic cardiology studies
  • Vascular consults
  • Vascular studies

Patient Transfers – One Call 24/7